Zilretta
Sponsors
University of Kansas Medical Center, Austin V Stone, Sorrento Therapeutics, Inc., Ohio State University, Pacira Pharmaceuticals, Inc
Conditions
Anterior Cruciate Ligament TearGlenohumeral OsteoarthritisKnee OsteoarthritisKnee Pain ChronicOsteoarthritis of HipOsteoarthritis, KneeTibial Meniscus InjuriesTibial Meniscus Tears
Phase 2
Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
TerminatedNCT04331002
Start: 2020-08-21End: 2022-07-11Updated: 2023-07-27
Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis
NCT04885972
Start: 2021-11-15End: 2023-11-30Updated: 2023-01-17
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
TerminatedNCT06977568
Start: 2025-07-25End: 2025-10-16Updated: 2025-12-22
Phase 3
Phase 4
The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
CompletedNCT03895840
Start: 2018-03-19End: 2021-05-03Updated: 2022-05-05
Trial Comparing Three Single Dose Injections for Knee Osteoarthritis
TerminatedNCT05492851
Start: 2022-08-02End: 2023-01-11Updated: 2026-09-17